5AM Partners VI, LLC - Feb 23, 2023 Form 3 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role
10%+ Owner
Signature
5AM Partners VI, LLC, By /s/ Kush Parmar, Managing Member
Stock symbol
ELVN
Transactions as of
Feb 23, 2023
Transactions value $
$0
Form type
3
Date filed
3/6/2023, 04:18 PM
Previous filing
Aug 17, 2022
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ELVN Common Stock 4.84M Feb 23, 2023 By 5AM Ventures VI, L.P. F1
holding ELVN Common Stock 960K Feb 23, 2023 By 5AM Opportunities I, L.P. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.
F2 The shares are directly held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Dr. Parmar disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.